Topical Tranexamic Acid Reduces Blood Loss in Minimally Invasive Total Knee Arthroplasty Receiving Rivaroxaban

Shih-Hsiang Yen, Po-Chun Lin, Bradley Chen, Chung-Chen Huang, Jun-Wen Wang, Shih-Hsiang Yen, Po-Chun Lin, Bradley Chen, Chung-Chen Huang, Jun-Wen Wang

Abstract

Background: It is unclear whether topical (intra-articular) or intravenous TXA reduces blood loss in minimally invasive TKA patients receiving a direct oral anticoagulant for thromboprophylaxis. This study is to investigate whether TXA given intravenously or intra-articularly is effective in reducing blood loss in minimally invasive TKA patients using rivaroxaban for thromboprophylaxis.

Methods: Ninety-three patients who underwent primary minimally invasive TKA were divided into placebo group (30 patients) that received saline both intravenously and intra-articularly, intravenous (IV) group (31 patients) that received 1 g TXA intravenously, and topical group (32 patients) that received 3 g TXA in 100 ml saline intra-articularly. All patients received oral rivaroxaban of 10 mg daily for 14 days postoperatively.

Results: p < 0.001 and p = 0.041. The mean total blood loss was 1131 mL (567-1845) in placebo, which was higher than that in the IV group (921 mL; range, 465-1495; p = 0.014) and the topical group (795 mL; range, 336-1350; p < 0.001). The total blood loss did not differ between the IV and the topical group (p = 0.179).

Conclusion: This prospective, randomized, controlled trial demonstrated an equal efficacy of TXA in blood conservation when administered intravenously or topically in minimally invasive TKA patients receiving rivaroxaban for thromboprophylaxis.

Figures

Figure 1
Figure 1
Flow chart of patient selection and analysis throughout the study. IV: intravenous, MIS: minimally invasive surgery, and TKA: total knee arthroplasty.

References

    1. Bierbaum B. E., Hill C., Callaghan J. J., et al. An analysis of blood management in patients having a total hip or knee arthroplasty. The Journal of Bone & Joint Surgery—American Volume. 1999;81(1):2–10. doi: 10.2106/00004623-199901000-00002.
    1. Callaghan J. J., O'Rourke M. R., Liu S. S. Blood management: issues and options. The Journal of Arthroplasty. 2005;20(2):51–54. doi: 10.1016/j.arth.2005.03.018.
    1. Keating E. M., Meding J. B., Faris P. M., Ritter M. A. Predictors of transfusion risk in elective knee surgery. Clinical Orthopaedics and Related Research. 1998;(357):50–59. doi: 10.1097/00003086-199812000-00008.
    1. Bong M. R., Patel V., Chang E., Issack P. S., Hebert R., Di Cesare P. E. Risks associated with blood transfusion after total knee arthroplasty. The Journal of Arthroplasty. 2004;19(3):281–287. doi: 10.1016/j.arth.2003.10.013.
    1. Goodnough L. T., Verbrugge D., Marcus R. E. The relationship between hematocrit, blood lost, and blood transfused in total knee replacement. Implications for postoperative blood salvage and reinfusion. American Journal of Knee Surgery. 1995;8(3):83–87.
    1. Tanaka N., Sakahashi H., Sato E., Hirose K., Ishima T., Ishii S. Timing of the administration of tranexamic acid for maximum reduction in blood loss in arthroplasty of the knee. The Journal of Bone & Joint Surgery—British Volume. 2001;83(5):702–705. doi: 10.1302/0301-620x.83b5.11745.
    1. Benoni G., Fredin H. Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients. The Journal of Bone & Joint Surgery—British Volume. 1996;78(3):434–440.
    1. Hiippala S., Strid L., Wennerstrand M., et al. Tranexamic acid (Cyklokapron) reduces perioperative blood loss associated with total knee arthroplasty. British Journal of Anaesthesia. 1995;74(5):534–537. doi: 10.1093/bja/74.5.534.
    1. Ido K., Neo M., Asada Y., et al. Reduction of blood loss using tranexamic acid in total knee and hip arthroplasties. Archives of Orthopaedic and Trauma Surgery. 2000;120(9):518–520. doi: 10.1007/s004029900132.
    1. Lin P.-C., Hsu C.-H., Chen W.-S., Wang J.-W. Does tranexamic acid save blood in minimally invasive total knee arthroplasty? Clinical Orthopaedics and Related Research. 2011;469(7):1995–2002. doi: 10.1007/s11999-011-1789-y.
    1. Lin P.-C., Hsu C.-H., Huang C.-C., Chen W.-S., Wang J.-W. The blood-saving effect of tranexamic acid in minimally invasive total knee replacement: Is an additional pre-operative injection effective? The Journal of Bone & Joint Surgery (British Volume) 2012;94(7):932–936. doi: 10.1302/0301-620X.94B7.28386.
    1. Alshryda S., Sarda P., Sukeik M., Nargol A., Blenkinsopp J., Mason J. M. Tranexamic acid in total knee replacement: a systematic review and meta-analysis. The Journal of Bone & Joint Surgery—British Volume. 2011;93(12):1577–1585. doi: 10.1302/0301-620x.93b12.26989.
    1. Cid J., Lozano M. Tranexamic acid reduces allogeneic red cell transfusions in patients undergoing total knee arthroplasty: results of a meta-analysis of randomized controlled trials. Transfusion. 2005;45(8):1302–1307. doi: 10.1111/j.1537-2995.2005.00204.x.
    1. Ho K. M., Ismail H. Use of intravenous tranexamic acid to reduce allogeneic blood transfusion in total hip and knee arthroplasty: A meta-analysis. Anaesthesia and Intensive Care. 2003;31(5):529–537.
    1. Yang Z.-G., Chen W.-P., Wu L.-D. Effectiveness and safety of tranexamic acid in reducing blood loss in total knee arthroplasty: A meta-analysis. The Journal of Bone & Joint Surgery. 2012;94(13):1153–1159. doi: 10.2106/JBJS.K.00873.
    1. Zhang H., Chen J., Chen F., Que W. The effect of tranexamic acid on blood loss and use of blood products in total knee arthroplasty: a meta-analysis. Knee Surgery, Sports Traumatology, Arthroscopy: official journal of the ESSKA. 2012;20(9):1742–1752. doi: 10.1007/s00167-011-1754-z.
    1. Wong J., Abrishami A., El Beheiry H., et al. Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial. The Journal of Bone and Joint Surgery—American Volume. 2010;92(15):2503–2513. doi: 10.2106/jbjs.i.01518.
    1. Georgiadis A. G., Muh S. J., Silverton C. D., Weir R. M., Laker M. W. A Prospective double-blind placebo controlled trial of topical tranexamic acid in total knee arthroplasty. The Journal of Arthroplasty. 2013;28(8):78–82. doi: 10.1016/j.arth.2013.03.038.
    1. Gomez-Barrena E., Ortega-Andreu M., Padilla-Eguiluz N. G., Pérez-Chrzanowska H., Figueredo-Zalve R. Topical intra-articular compared with intravenous tranexamic acid to reduce blood loss in primary total knee replacement: A double-blind, randomized, controlled, noninferiority clinical trial. Journal of Bone and Joint Surgery - American Volume. 2014;96(23):1937–1944. doi: 10.2106/JBJS.N.00060.
    1. Ishida K., Tsumura N., Kitagawa A., et al. Intra-articular injection of tranexamic acid reduces not only blood loss but also knee joint swelling after total knee arthroplasty. International Orthopaedics. 2011;35(11):1639–1645. doi: 10.1007/s00264-010-1205-3.
    1. Panteli M., Papakostidis C., Dahabreh Z., Giannoudis P. V. Topical tranexamic acid in total knee replacement: a systematic review and meta-analysis. The Knee. 2013;20(5):300–309. doi: 10.1016/j.knee.2013.05.014.
    1. Bonutti P. M., Mont M. A., McMahon M., Ragland P. S., Kester M. Minimally invasive total knee arthroplasty. The Journal of bone and joint surgery (American volume) 2004;86(2):26–31. doi: 10.2106/00004623-200412002-00005.
    1. Tria A. J., Jr. Advancements in minimally invasive total knee arthroplasty. Orthopedics. 2003;26(8):s859–s863.
    1. Haas S. B., Cook S., Beksac B. Minimally invasive total knee replacement through a mini midvastus approach: A comparative study. Clinical Orthopaedics and Related Research. 2004;(428):68–73. doi: 10.1097/.
    1. Tashiro Y., Miura H., Matsuda S., Okazaki K., Iwamoto Y. Minimally invasive versus standard approach in total knee arthroplasty. Clinical Orthopaedics and Related Research. 2007;(463):144–150. doi: 10.1097/BLO.0b013e31814a5100.
    1. Benoni G., Fredin H., Knebel R., Nilsson P. Blood conservation with tranexamic acid in total hip arthroplasty: a randomized, double-blind study in 40 primary operations. Acta Orthopaedica. 2001;72(5):442–448. doi: 10.1080/000164701753532754.
    1. Owens W. D., Felts J. A., Spitznagel E. L., Jr. ASA physical status classifications: a study of consistency of ratings. Anesthesiology. 1978;49(4):239–243. doi: 10.1097/00000542-197810000-00003.
    1. Pearse E. O., Caldwell B. F., Lockwood R. J., Hollard J. Early mobilisation after conventional knee replacement may reduce the risk of post-operative venous thromboembolism. The Journal of Bone & Joint Surgery (British Volume) 2007;89(3):316–322. doi: 10.1302/0301-620X.89B3.18196.
    1. Nadler S. B., Hidalgo J. U., Bloch T. Prediction of blood volume in normal human adults. Surgery. 1962;51(2):224–232.
    1. Wells P., Anderson D. R., Bormanis J., et al. Value of assessment of pretest probability of deep-vein thrombosis in clinical management. The Lancet. 1997;350(9094):1795–1798. doi: 10.1016/S0140-6736(97)08140-3.
    1. Rabinov K., Paulin S. Roentgen diagnosis of venous thrombosis in the leg. JAMA Surgery. 1972;104(2):134–144. doi: 10.1001/archsurg.1972.04180020014004.
    1. Soni A., Saini R., Gulati A., Paul R., Bhatty S., Rajoli S. R. Comparison Between Intravenous and Intra-articular Regimens of Tranexamic Acid in Reducing Blood Loss During Total Knee Arthroplasty. The Journal of Arthroplasty. 2014;29(8):1525–1527. doi: 10.1016/j.arth.2014.03.039.
    1. Maniar R. N., Kumar G., Singhi T., Nayak R. M., Maniar P. R. Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients. Clinical Orthopaedics and Related Research. 2012;470(9):2605–2612. doi: 10.1007/s11999-012-2310-y.
    1. Chen J. Y., Chin P. L., Moo I. H., et al. Intravenous versus intra-articular tranexamic acid in total knee arthroplasty: A double-blinded randomised controlled noninferiority trial. The Knee. 2016;23(1):152–156. doi: 10.1016/j.knee.2015.09.004.
    1. Keyhani S., Esmailiejah A. A., Abbasian M. R., Safdari F. Which route of tranexamic acid administration is more effective to reduce blood loss following total knee arthroplasty? Archives of Bone and Joint Surgery. 2016;4(1):65–69.
    1. Patel J. N., Spanyer J. M., Smith L. S., Huang J., Yakkanti M. R., Malkani A. L. Comparison of Intravenous versus Topical Tranexamic Acid in Total Knee Arthroplasty: A Prospective Randomized Study. The Journal of Arthroplasty. 2014;29(8):1528–1531. doi: 10.1016/j.arth.2014.03.011.
    1. Konig G., Hamlin B. R., Waters J. H. Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty. The Journal of Arthroplasty. 2013;28(9):1473–1476. doi: 10.1016/j.arth.2013.06.011.
    1. Seo J.-G., Moon Y.-W., Park S.-H., Kim S.-M., Ko K.-R. The comparative efficacies of intra-articular and IV tranexamic acid for reducing blood loss during total knee arthroplasty. Knee Surgery, Sports Traumatology, Arthroscopy: official journal of the ESSKA. 2013;21(8):1869–1874. doi: 10.1007/s00167-012-2079-2.
    1. Shaieb M. D., Watson B. N., Atkinson R. E. Bleeding complications with enoxaparin for deep venous thrombosis prophylaxis. The Journal of Arthroplasty. 1999;14(4):432–438. doi: 10.1016/S0883-5403(99)90098-0.
    1. Trkulja V., Kolundžic R. Rivaroxaban vs dabigatran for thromboprophylaxis after joint-replacement surgery: Exploratory indirect comparison based on metaanalysis of pivotal clinical trials. Croatian Medical Journal. 2010;51(2):113–123. doi: 10.3325/cmj.2010.51.113.
    1. Aguilera X., Martínez-Zapata M. J., Hinarejos P., et al. Topical and intravenous tranexamic acid reduce blood loss compared to routine hemostasis in total knee arthroplasty: a multicenter, randomized, controlled trial. Archives of Orthopaedic and Trauma Surgery. 2015;135(7):1017–1025. doi: 10.1007/s00402-015-2232-8.
    1. Levine M. N., Raskob G., Beyth R. J., Kearon C., Schulman S. Hemorrhagic complications of anticoagulant treatment: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. CHEST. 2004;126(3 supplement):287S–310S. doi: 10.1378/chest.126.3_suppl.287S.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться